[Treatment of patients with chronic coronary insufficiency].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D045930:Anabolic Agents / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000188:drug therapy; D001920:Bradykinin / Q000627:therapeutic use; D002908:Chronic Disease; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D045930:Anabolic Agents; D013956:Antithyroid Agents; D006993:Hypnotics and Sedatives; D008996:Monoamine Oxidase Inhibitors; D014149:Tranquilizing Agents; D014665:Vasodilator Agents; D001920:Bradykinin
Lechenie bol'nykh khronicheskoĭ koronarnoĭ nedostatochnost'iu.